Advanced Enzyme [ADVENZYMES] vs Grauer & Weil [GRAUWEIL] Detailed Stock Comparison
Advanced Enzyme
NSE
Loading...
Grauer & Weil
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Advanced Enzyme wins in 12 metrics, Grauer & Weil wins in 8 metrics, with 0 ties. Advanced Enzyme appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Advanced Enzyme | Grauer & Weil | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.13 | 26.73 | Advanced Enzyme |
| Price-to-Book Ratio | 2.42 | 4.48 | Advanced Enzyme |
| Debt-to-Equity Ratio | 2.68 | 1.26 | Grauer & Weil |
| PEG Ratio | 1.47 | 37.25 | Advanced Enzyme |
| EV/EBITDA | 15.56 | 20.89 | Advanced Enzyme |
| Profit Margin (TTM) | 20.48% | 13.35% | Advanced Enzyme |
| Operating Margin (TTM) | 25.18% | 18.36% | Advanced Enzyme |
| EBITDA Margin (TTM) | 25.18% | 18.36% | Advanced Enzyme |
| Return on Equity | 8.93% | 16.73% | Grauer & Weil |
| Return on Assets (TTM) | 8.09% | 12.23% | Grauer & Weil |
| Free Cash Flow (TTM) | $1.08B | $999.80M | Advanced Enzyme |
| Dividend Yield | 1.56% | 1.05% | Advanced Enzyme |
| 1-Year Return | -28.36% | -0.82% | Grauer & Weil |
| Price-to-Sales Ratio (TTM) | 5.14 | 3.74 | Grauer & Weil |
| Enterprise Value | $29.31B | $36.79B | Grauer & Weil |
| EV/Revenue Ratio | 4.39 | 3.27 | Grauer & Weil |
| Gross Profit Margin (TTM) | 73.08% | 41.05% | Advanced Enzyme |
| Revenue per Share (TTM) | $60 | $25 | Advanced Enzyme |
| Earnings per Share (Diluted) | $12.22 | $3.47 | Advanced Enzyme |
| Beta (Stock Volatility) | 0.37 | 0.28 | Grauer & Weil |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Advanced Enzyme vs Grauer & Weil Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Advanced Enzyme | 0.65% | -1.60% | -4.70% | 7.21% | -0.50% | -12.42% |
| Grauer & Weil | 0.11% | -2.32% | -11.54% | 9.08% | 6.92% | -11.88% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Advanced Enzyme | -28.36% | 15.08% | 30.43% | 7.83% | 7.83% | 7.83% |
| Grauer & Weil | -0.82% | 39.06% | 116.96% | 385.60% | 953.98% | 726.65% |
Performance & Financial Health Analysis: Advanced Enzyme vs Grauer & Weil
| Metric | ADVENZYMES | GRAUWEIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹34.36B | ₹42.05B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 666,128 | 141,218 |
| 90 Day Avg. Volume | 479,369 | 163,561 |
| Last Close | ₹309.10 | ₹92.85 |
| 52 Week Range | ₹257.90 - ₹571.00 | ₹78.00 - ₹120.00 |
| % from 52W High | -45.87% | -22.63% |
| All-Time High | ₹571.00 (Sep 16, 2024) | ₹204.80 (Feb 26, 2024) |
| % from All-Time High | -45.87% | -54.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | -0.04% |
| Quarterly Earnings Growth | 0.17% | -0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.13% |
| Operating Margin (TTM) | 0.25% | 0.18% |
| Return on Equity (TTM) | 0.09% | 0.17% |
| Debt to Equity (MRQ) | 2.68 | 1.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹127.00 | ₹20.72 |
| Cash per Share (MRQ) | ₹52.94 | ₹11.87 |
| Operating Cash Flow (TTM) | ₹1.70B | ₹1.68B |
| Levered Free Cash Flow (TTM) | ₹1.31B | ₹1.57B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.56% | 1.05% |
| Last 12-Month Dividend | ₹5.20 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Advanced Enzyme vs Grauer & Weil
| Metric | ADVENZYMES | GRAUWEIL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.13 | 26.73 |
| Forward P/E | 24.67 | 37.25 |
| PEG Ratio | 1.47 | 37.25 |
| Price to Sales (TTM) | 5.14 | 3.74 |
| Price to Book (MRQ) | 2.42 | 4.48 |
| Market Capitalization | ||
| Market Capitalization | ₹34.36B | ₹42.05B |
| Enterprise Value | ₹29.31B | ₹36.79B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.39 | 3.27 |
| Enterprise to EBITDA | 15.56 | 20.89 |
| Risk & Other Metrics | ||
| Beta | 0.37 | 0.28 |
| Book Value per Share (MRQ) | ₹127.00 | ₹20.72 |
Financial Statements Comparison: Advanced Enzyme vs Grauer & Weil
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ADVENZYMES | GRAUWEIL |
|---|---|---|
| Revenue/Sales | ₹1.86B | ₹3.40B |
| Cost of Goods Sold | ₹500.49M | ₹2.00B |
| Gross Profit | ₹1.36B | ₹1.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹468.14M | ₹237.20M |
| EBITDA | ₹652.82M | ₹417.40M |
| Pre-Tax Income | ₹549.00M | ₹343.50M |
| Income Tax | ₹144.60M | ₹86.10M |
| Net Income (Profit) | ₹404.40M | ₹257.40M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ADVENZYMES | GRAUWEIL |
|---|---|---|
| Cash & Equivalents | ₹942.25M | ₹1.08B |
| Total Current Assets | ₹8.80B | ₹9.36B |
| Total Current Liabilities | ₹967.55M | ₹2.97B |
| Long-Term Debt | ₹209.17M | ₹37.30M |
| Total Shareholders Equity | ₹14.69B | ₹9.39B |
| Retained Earnings | ₹11.53B | N/A |
| Property, Plant & Equipment | ₹2.93B | ₹2.47B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ADVENZYMES | GRAUWEIL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ADVENZYMES | GRAUWEIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 666,128 | 141,218 |
| Average Daily Volume (90 Day) | 479,369 | 163,561 |
| Shares Outstanding | 111.88M | 453.41M |
| Float Shares | 29.32M | 127.47M |
| % Held by Insiders | 0.56% | 0.72% |
| % Held by Institutions | 0.21% | 0.00% |
Dividend Analysis & Yield Comparison: Advanced Enzyme vs Grauer & Weil
| Metric | ADVENZYMES | GRAUWEIL |
|---|---|---|
| Last 12-Month Dividend | ₹5.20 | ₹1.00 |
| Last 12-Month Dividend Yield | 1.56% | 1.05% |
| 3-Year Avg Annual Dividend | ₹5.43 | ₹0.58 |
| 3-Year Avg Dividend Yield | 0.75% | 0.45% |
| 3-Year Total Dividends | ₹16.30 | ₹1.73 |
| Ex-Dividend Date | Jul 23, 2025 | Aug 06, 2025 |